OOIR: Observatory of International Research

Papers

(The median citation count of Journal of the American College of Cardiology is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Long-Duration Space Flight and Cardiac Morphology	1834
IMPACT OF GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS ON ATRIAL ARRHYTHMIAS IN ADVANCED HEART FAILURE: A POST-HOC ANALYSIS FROM FIGHT	1507
THE EFFECT OF AN ONLINE LEARNING MODULE ON TRAINEE UNDERSTANDING AND TROUBLESHOOTING OF MECHANICAL CIRCULATORY SUPPORT DEVICES IN THE CICU	1086
ATRIAL SHUNTING PROTECTS AGAINST LONGITUDINAL WORSENING OF RIGHT VENTRICULAR FREE WALL STRAIN IN HFPEF/HFMREF: FINDINGS FROM REDUCE-LAP HF	872
FIRST CASE REPORT ON A RARE COMBINATION OF TWO UNUSUAL ANOMALIES: ABERRANT LEFT MAIN ARTERY ARISING FROM RIGHT CORONARY SINUS WITH CONGENITAL ABSENCE OF LEFT CIRCUMFLEX ARTERY	671
LONGITUDINAL CONTRACTILE DIASTASIS: A NOVEL MYOCARDIAL CONTRACTION-RELAXATION ABNORMALITY IN PATIENTS WITH AMYLOID CARDIOMYOPATHY	578
CATHTAB-LM: AN EFFICIENT LARGE LANGUAGE MODEL FOR AUTOMATED TRANSFORMATION OF UNSTRUCTURED CARDIAC CATHETERIZATION REPORTS INTO STRUCTURED DATASETS	515
CLINICAL OUTCOMES OF PULMONARY VEIN ISOLATION VERSUS ANTIARRHYTHMIC DRUGS AS FIRST-LINE THERAPY FOR ATRIAL FIBRILLATION: A PROPENSITY SCORE-MATCHED ANALYSIS	470
TEMPORAL AND GEOGRAPHICAL PATTERNS OF ISCHEMIC HEART DISEASE ATTRIBUTABLE TO PARTICULATE MATTER POLLUTION: A GLOBAL COMPREHENSIVE ANALYSIS FROM 1990 TO 2021	439
IMPROVING ACCESS TO CARDIAC CARE IN RURAL AREAS - NARRATIVE INSIGHTS FROM PROJECT CARDIOGRAM, A DIGITAL HEALTH IMPLEMENTATION SCIENCE PROJECT	394
VARICELLA ZOSTER VIRUS-RELATED MYOPERICARDITIS	394
AGE AND COMORBIDITIES ASSOCIATED WITH HEALTHCARE UTILIZATION AFTER RECEIVING A SMARTWATCH IRREGULAR PULSE NOTIFICATION SUGGESTIVE OF ATRIAL FIBRILLATION: FINDINGS FROM THE APPLE HEART STUDY	394
PULMONARY ENDARTERECTOMY: A LIFE CHANGING PROCEDURE FOR CTEPH	373
PATTERNS OF DIURETIC MANAGEMENT ON LENGTH OF STAY IN ACUTE HEART FAILURE WITH SERUM CREATININE INCREASES	347
PACING THROUGH THE COMPLICATIONS: FROM TEER TO TTVR TO PACEMAKER IN TRICUSPID VALVE REPAIR	346
STATEWIDE BURDEN AND TREND OF NON-RHEUMATIC CALCIFIC AORTIC VALVE DISEASE IN THE UNITED STATES FROM 1990-2021: AN INSIGHT FROM THE GLOBAL BURDEN OF DISEASE STUDY 2021	316
DISPARITIES IN MORTALITY AND RESOURCE UTILIZATION FOR ACUTE CORONARY SYNDROME WITH MECHANICAL SUPPORT DEVICES: A COMPARATIVE ANALYSIS OF WEEKEND VS. WEEKDAY ADMISSIONS USING NATIONAL INPATIENT DATA	312
COMPARISON OF ARTIFICIAL INTELLIGENCE MODELS FOR DETECTING LEFT VENTRICULAR SYSTOLIC DYSFUNCTION: A META-ANALYSIS OF CNN, DEEP LEARNING, AND DYNAMIC NEURAL NETWORKS	304
RIGHT VENTRICULAR CARDIAC RESYNCHRONIZATION IN A PATIENT WITH DEXTROCARDIA, CARDIOMYOPATHY, AND RIGHT BUNDLE BRANCH BLOCK	300
SAFETY EVENTS INVOLVING THE ANGIO-SEAL VIP DEVICE: A COMPREHENSIVE ANALYSIS FROM THE MAUDE DATABASE (2005-2024)	286
GOOD PERICARDIUM GIVEN A BAD WRAP: A RESTRICTIVE CARDIOMYOPATHY MASQUERADING AS CONSTRICTIVE PERICARDITIS	274
PHENOTYPES OF NON-ISCHEMIC REFRACTORY VENTRICULAR TACHYCARDIA/VENTRICULAR FIBRILLATION OUT-OF-HOSPITAL CARDIAC ARREST PATIENTS RECEIVING EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION	272
ASPIRIN DISCONTINUATION WITHIN 1 MONTH VS AT 3 MONTHS WITH TICAGRELOR MONOTHERAPY IN ACUTE CORONARY SYNDROME: AN INDIVIDUAL PATIENT DATA POOLED ANALYSIS OF TICO AND T-PASS TRIALS	264
ASSOCIATION OF FRAILTY AND HIGH SENSITIVITY C-REACTIVE PROTEIN WITH CARDIOVASCULAR DISEASE IN MIDDLE-AGED AND OLDER ADULTS: A NATIONWIDE PROSPECTIVE COHORT STUDY	257
SUCCESSFUL PERCUTANEOUS CLOSURE OF MITRAL VALVE PERIVALVULAR LEAK CAUSING SEVERE HEMOLYTIC ANEMIA WITH AMPLATZER DUCT OCCLUDER	243

CARDIAC MANIFESTATIONS OF MESOAMERICAN NEPHROPATHY	225
DYNAMIC LEFT VENTRICULAR OUTFLOW TRACT OBSTRUCTION IN AN ELDERLY WOMAN: A CASE OF RECURRENT SYNCOPE AND ACUTE DECOMPENSATION	211
OUTCOMES OF MECHANICAL THROMBECTOMY VERSUS SYSTEMIC THROMBOLYSIS AMONG PATIENTS WITH PULMONARY EMBOLISM: A NATIONWIDE STUDY	210
ONE BIRD WITH TWO STONES: LEFT ATRIAL APPENDAGE OCCLUSION USING TWO DIFFERENT DEVICES	202
GET WITH THE GUIDELINES FOR HEART FAILURE: A BRIEF EDUCATIONAL INTERVENTION FOR RESIDENTS	186
HEART’S WILD TANGO: A TALE OF ARVC	183
SCHOOL READINESS AMONG U.S. CHILDREN WITH AND WITHOUT CONGENITAL HEART CONDITIONS, NATIONAL SURVEY OF CHILDREN’S HEALTH 2022	181
PATIENT SHOCKED BY WEIGHT LOSS: A CASE OF INAPPROPRIATE IMPLANTABLE CARDIOVERTER DEFIBRILLATOR FIRING	180
STATIN-INDUCED RHABDOMYOLYSIS IN A PATIENT WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA: A CASE REPORT AND CLINICAL IMPLICATIONS	180
MANAGING CARDIAC RISKS IN PREGNANCY WITH LEFT VENTRICULAR NONCOMPACTION CARDIOMYOPATHY AND EBSTEIN’S ANOMALY	179
OUTCOMES OF PROTAMINE IN PATIENTS UNDERGOING TRANSCATHETER AORTIC VALVE REPLACEMENT: A SYSTEMATIC REVIEW AND META-ANALYSIS	175
RARE CASE OF HEPATIC ENCEPHALOPATHY TRIGGERED BY CARDIAC CIRRHOSIS	169
CONCURRENT PULMONARY FIBROSIS AND PULMONARY ARTERIAL HYPERTENSION APPROACHED BY CARDIOPULMONARY EXERCISE TESTING, AN ILLUSTRATIVE CASE REPORT	163
MEDICARE PRICE NEGOTIATION FOR 10 PRESCRIPTION DRUGS (2026): QUANTIFYING THE IMPACTS ON HEART FAILURE TREATMENT	162
INCIDENCE AND OUTCOMES OF PROSTHETIC VALVE ENDOCARDITIS IN ADULTS WITH CONGENITAL HEART DISEASE	158
CONCURRENT IMMUNE CHECKPOINT INHIBITOR INDUCED MYOCARDITIS & MYASTHENIA GRAVIS	158
WHEN HEART TRANSPLANTATION IS NOT AN OPTION IN COMPLEX CONGENITAL HEART DISEASES IN ADULTS: FONTAN SURGERY	157
EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND CARDIOVASCULAR DISEASES (EXACOS-CV): ONE IN THREE COPD PATIENTS EXPERIENCED CARDIOPULMONARY EVENTS DURING FOLLOW-UP	156
A RARE CASE OF METASTATIC RENAL CELL CARCINOMA WITH DIRECT CARDIAC EXTENSION	154
BEWARE OF FLECAINIDE TOXICITY: A CASE REPORT	154
LOST THE GRASP — A CASE OF MITRACLIP SINGLE-LEAFLET DETACHMENT	153
A CASE OF AN ANOMALOUS RIGHT CORONARY ARTERY ARISING FROM A SINGLE CORONARY ARTERY ORIGIN	152
EFFECT OF TIME TO EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION ON SURVIVAL OUTCOMES IN OUT OF HOSPITAL AND IN HOSPITAL CARDIAC ARREST PATIENTS	150
FROM CYSTITIS TO CARDIAC ARREST: A FULMINANT MYOCARDITIS SCENARIO CAUSED BY ADENOVIRUS	149
CORONARY-CAMERAL FISTULA DISCOVERED IN A PATIENT PRESENTING AS NSTEMI AND ACUTE HEART FAILURE: A CLINICAL RARITY	147
ASYMPTOMATIC HYPOXEMIA: FROM URGENT CARE TO ECMO	145
INFECTIVE ENDOCARDITIS AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT UNDERGOING SURGICAL MANAGEMENT: INSIGHTS FROM A TERTIARY CARE CENTER OF EXCELLENCE	143
IMPACT OF DIFFERENT OBESITY PHENOTYPES ON IN-HOSPITAL MORTALITY IN ELDERLY CARDIAC ARREST RELATED HOSPITALIZATIONS; A POPULATION BASED MULTI CENTER PERSPECTIVE	143
RIVAROXABAN AND WALKING ABILITY IN PATIENTS WITH SYMPTOMATIC PERIPHERAL ARTERY DISEASE AFTER LOWER EXTREMITY REVASCULARIZATION: INSIGHTS FROM VOYAGER PAD	143
IMPACT OF MUSCULOSKELETAL FEATURES ON NON-SYNDROMIC ANEURYSMS: AN ANALYSIS OF THE SEVERITY OF VASCULAR OUTCOMES	140
NAVIGATING CARDIOTOXICITY IN BREAST CANCER THERAPY: EVALUATING THE PREDICTIVE STRENGTH OF THE HFA-ICOS RISK STRATIFICATION TOOL	139
PERSISTENT LEFT SUPERIOR VENA CAVA ISOLATION WITH PULSED-FIELD ABLATION	139
CARDIOVASCULAR OUTCOMES OF EMPAGLIFLOZIN IN PATIENTS WITH AND WITHOUT TYPE 2 DIABETES MELLITUS; A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS	139
IMPLANTABLE LOOP RECORDER MALFUNCTION FOLLOWING CARDIOVERSION: MISSED SIGNAL LOSS AND DEVICE FAILURE IN THE ABSENCE OF REMOTE MONITORING ALERTS	139
INTERNATIONAL EXPERIENCE OF EFFICACY AND OUTCOMES OF HIGH RISK PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY WITH IMPLANTED CARDIOVERTER DEFIBRILLATORS	139
HIDDEN IN PLAIN SIGHT; HISTOPLASMA ENDOCARDITIS IN A PATIENT WITH DISSEMINATED INFECTION AND AIDS	138
ARRHYTHMOGENIC RISK IN V142I TRANSTHYRETIN AMYLOID CARDIOMYOPATHY	138
LEFT ATRIAL MASS IN A PATIENT WITH WEGENER’S GRANULOMATOSIS: A RARE CASE OF PYREXIA OF UNKNOWN ORIGIN MIMICKING INFECTIVE ENDOCARDITIS	135
PREDICTORS AND TEMPORAL TRENDS OF HIGH-POTENCY P2Y12 INHIBITOR USE AFTER PERCUTANEOUS CORONARY INTERVENTION FOR ACUTE CORONARY SYNDROME (ACS): IMPACT OF ISAR-REACT 5 AND 2021 ACC/AHA REVASCULARIZATION	133
CLINICAL CHARACTERISTICS AND LONGITUDINAL OUTCOMES OF A SOUTHEAST ASIAN TRANSCATHETER AORTIC VALVULAR IMPLANTATION REGISTRY	133
MYOCARDIAL FIBROSIS AND VENTRICULAR ARRHYTHMIA AFTER LVAD IMPLANTATION	131
MECHANICAL CIRCULATORY SUPPORT IN FEMALES WITH SPONTANEOUS CORONARY ARTERY DISSECTION AND CARDIOGENIC SHOCK: TRENDS, PREDICTORS, AND SURVIVAL INSIGHTS	130
CONSTRICTIVE PERICARDITIS AS A RARE MANIFESTATION OF ISOLATED CARDIAC TUBERCULOSIS	129
IS CARDIONEUROABLATION A SAFE THERAPEUTIC APPROACH FOR NEUROCARDIOGENIC SYNCOPE?	129
DIFFUSION TENSOR CARDIAC MAGNETIC RESONANCE FOR CONTRAST-FREE DETECTION OF EARLY CARDIAC AMYLOIDOSIS IN CARPAL TUNNEL SYNDROME	129
HYPERTENSIVE RESPONSE DURING DOBUTAMINE STRESS ECHOCARDIOGRAPHY AND RISK OF NEW ONSET HEART FAILURE	129
FIRST IMPELLA RP FLEX PLACED DURING OPEN HEART SURGERY IN THE USA	129
INTRACARDIAC ECHOCARDIOGRAPHY VERSUS TRANSESOPHAGEAL ECHOCARDIOGRAPHY GUIDANCE ON LEFT ATRIAL APPENDAGE OCCLUSION IN PATIENTS WITH ATRIAL FIBRILLATION: A SYSTEMATIC REVIEW AND META-ANALYSIS	129
A MISTERY OF THE RIGHT ATRIUM: UNUSUAL FINDINGS IN A COMPLEX CARDIAC CASE	125
DOUBLE JEOPARDY: LEFT VENTRICULAR ANEURYSM AND VENTRICULAR SEPTAL DEFECT POSTMYOCARDIAL INFARCTION	124

SUCCESSFUL RIGHT SUBCLAVIAN IMPELLA PLACEMENT IN A PATIENT WITH COARCTATION OF THE AORTA AND SMALL FEMORAL ARTERIES: A NOVEL APPROACH FOR MECHANICAL CIRCULATORY SUPPORT	122
ASSESSING THE IMPACT OF HOSPITAL VOLUME THRESHOLDS ON IN-HOSPITAL MORTALITY AMONG HEART TRANSPLANT PATIENTS: AN ANALYSIS OF THE NATIONAL INPATIENT SAMPLE (2017-2021)	121
“WHAT THE MOJO!”A CASE REPORT OF SYNTHETIC CANNABINOID (MOJO) INDUCED ST SEGMENT ELEVATED MYOCARDIAL INFARCTION	121
EXPLORING STATIN UNDERUTILIZATION IN PATIENTS WITH LDL ≥ 190	120
COMPARATIVE OUTCOMES OF INTRACARDIAC VERSUS TRANSESOPHAGEAL ECHOCARDIOGRAPHY FOR LEFT ATRIAL APPENDAGE OCCLUSION: A SYSTEMATIC REVIEW AND META-ANALYSIS	117
ARTERIAL STIFFNESS PARAMETERS IN OLDER ADULTS WITH AND WITHOUT STANDING HYPERTENSION	117
SAFETY AND EFFICACY OF PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS UNDERGOING TRANSCATHETER AORTIC VALVE IMPLANTATION	115
LONG-TERM OUTCOMES IN YOUNG PATIENTS WITH SPONTANEOUS CORONARY ARTERY DISSECTION: A SYSTEMATIC REVIEW AND POOLED ANALYSIS	115
RISKS FOR SUDDEN CARDIAC (SCD) AND UNDETERMINED CAUSE OF DEATH (UDD) AMONG PEOPLE WITH HIV (PWH) IN THE REPRIEVE PRIMARY CARDIOVASCULAR PREVENTION TRIAL	115
CORONARY PLAQUE PATTERNS AMONG SYMPTOMATIC AND ASYMPTOMATIC PATIENTS: AN ADVANCE SUBSTUDY	114
CARDIOVASCULAR-KIDNEY-METABOLIC SYNDROME RISK FACTOR PREVALENCE, TREATMENT, AND CONTROL AMONG SOUTH ASIAN AND CHINESE AMERICANS	112
TEMPORAL CHANGES IN PREVALENCE AND SEVERITY OF PULMONARY HYPERTENSION AND RELATIONSHIP TO OUTCOMES IN COARCTATION OF AORTA	112
LOW QRS VOLTAGES AND QRS FRAGMENTATION IN ADOLESCENCE - FINDINGS FROM THE BEATIT SCREENING PROGRAM	109
RIGHT VENTRICULAR OUTFLOW TRACT VELOCITY TIME INTERVAL: AN INVALUABLE YET FORGOTTEN ECHOCARDIOGRAPHIC VARIABLE	108
RIGHT POSTERIOR DESCENDING ARTERY MYOCARDIAL BRIDGE MANIFESTING AS ST-ELEVATION MYOCARDIAL INFARCTION	104
TREATMENT OF SEVERE RIGHT-SIDED INFECTIVE ENDOCARDITIS WITH MECHANICAL ASPIRATION VERSUS VALVE SURGERY: COMPARISON OF OUTCOMES AND INSIGHTS FROM A UNITED STATES REAL-WORLD DATABASE	103
EVENTS OF MYOCARDIAL INFARCTION AMONG ADULTS WITH COCAINE OVERDOSE AND PREDICTORS OF MORTALITY; A RETROSPECTIVE STUDY INVOLVING 105695 CASES	103
INTENSIVE VS. STANDARD BLOOD PRESSURE MANAGEMENT IN HIGH-RISK CARDIOVASCULAR PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF MORTALITY AND ADVERSE EVENTS	103
A RARE CAUSE OF CONSTRICTIVE PERICARDITIS: PRIMARY PERICARDIAL MESOTHELIOMA	102
IMPACT OF TRICUSPID VALVE REPLACEMENT ON OUTCOMES IN TRANSPOSITION OF THE GREAT ARTERIES AND SYSTEMIC RIGHT VENTRICLE	102
MAPPING ACTIVATION IN THE INVERSE AREA (MAIA): A NOVEL TECHNIQUE TO RAPIDLY IDENTIFY GAPS IN PRIOR ABLATION LINES	102
CONTRAST-INDUCED ENCEPHALOPATHY AFTER PERCUTANEOUS CORONARY INTERVENTION WITH IOHEXOL	101
HIDDEN IN PLAIN SIGHT: A DECADE-LONG UNDETECTED PACEMAKER LEAD MISPLACEMENT	101
MASSIVE LEFT VENTRICULAR PSEUDOANEURYSM IN A PATIENT WITH PERSISTENT SYMPTOMS FOLLOWING SUSPECTED PNEUMONIA: A CASE REPORT	100
DETERMINING EXTENT OF NO REFLOW SOON AFTER REPERFUSION WITH MYOCARDIAL CONTRAST ECHOCARDIOGRAPHY USING INTRAVENOUS MICROBUBBLE ADMINISTRATION	99
UNCOVERING CRITICAL TRENDS: TRENDS IN 30-DAY READMISSION, MORTALITY, AND RESOURCE UTILIZATION AMONG FEMALE PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION AND BREAST CANCER	97
CULTURE-NEGATIVE ENDOCARDITIS COMPLICATED BY CARDIAC VALVULAR ANEURYSMS	96
CHANGING MORTALITY TRENDS IN CARDIOVASCULAR DISEASES: A COMPARATIVE ANALYSIS BEFORE, DURING, AND AFTER THE PANDEMIC	95
HEARTNAVIGATOR GUIDED TRANSCATHETER AORTIC VALVE REPLACEMENT IN A RADIOLUCENT BIOPROSTHETIC AORTIC VALVE	95
LEFT VENTRICULAR ASSIST DEVICE IMPLANTATION COMBINED WITH CRYOBALLOON ABLATION FOR VENTRICULAR TACHYCARDIA	93
MYOCARDIAL METABOLIC RESPONSE TO CABG SURGERY AS ASSESSED BY HYPERPOLARIZED CARBON-13 MRI	92
MECHANICAL TRICUSPID VALVE THROMBOSIS SUCCESSFULLY TREATED WITH ANTICOAGULATION	92
THE RISK AND REVERSIBILITY OF OSIMERTINIB-RELATED CARDIOTOXICITY IN A REAL-WORLD POPULATION	92
A RARE CASE OF SUCCESSFUL HEART TRANSPLANT IN A PATIENT WITH SPORADIC INCLUSION BODY MYOSITIS	91
IMPLICATIONS OF EXERCISE WEDGE PRESSURE IN HFPEF IDENTIFIED BY PRESSURE-FLOW SLOPE	91
CORONARY ARTERY FISTULAE ARE ASSOCIATED WITH THE APICAL VARIANT OF HYPERTROPHIC CARDIOMYOPATHY	90
INCREMENTAL PROGNOSTIC VALUE OF CARDIAC MAGNETIC RESONANCE BEYOND THE TRADITIONAL BIOMARKER STAGING SYSTEM IN TRANSTHYRETIN CARDIAC AMYLOIDOSIS	90
COMPARISON OF HOSPITAL OUTCOMES OF TRANSCATHETER MITRAL VALVE REPAIR WITH MITRACLIP BETWEEN PATIENTS <65 YEARS OLD VS PATIENTS <65 YEARS OLD	89
SEVERE AORTIC REGURGITATION IS ASSOCIATED WITH ELEVATED WALL SHEAR STRESS	89
IMPACT OF SMOKING ON BURDEN AND TRENDS OF AORTIC ANEURYSM ACROSS 204 COUNTRIES AND TERRITORIES: COMPARATIVE GLOBAL ANALYSIS FROM THE GLOBAL BURDEN OF DISEASE 2021	88
MACHINE LEARNING IDENTIFIES ABLATION AND VOLTAGE PARAMETERS TO PREDICT FIRST PASS ISOLATION AND ATRIAL FIBRILLATION RECURRENCE	87
GLP-1 RECEPTOR AGONISTS AND ATRIAL FIBRILLATION/ATRIAL FLUTTER IN PATIENTS WITH DIABETES: A RETROSPECTIVE ANALYSIS	87
PHENOTYPIC IMAGING PATTERNS ON MYOCARDIAL METABOLIC PET CAN CHARACTERIZE CARDIOVASCULAR OUTCOMES IN BIOPSY-PROVEN SARCOIDOSIS PATIENTS	86
COMPRESSING THE RIGHT VENTRICLE: AN UNUSUAL ETIOLOGY OF SHOCK	86
HIGHER REHOSPITALIZATION IN LEAN HEART FAILURE PATIENTS WITH REDUCED EJECTION FRACTION: A RETROSPECTIVE COHORT STUDY	86
FROM INFUSION TO DYSFUNCTION: REVEALING TAKOTSUBO CARDIOMYOPATHY AFTER POLATUZUMAB CHEMOTHERAPY	85
IMMUNE CHECKPOINT INHIBITOR MYOCARDITITS: A CHALLENGING CARDIOVASCULAR COMPLICATION	84
BATTLING CRITICAL DECISIONS: AMLODIPINE TOXICITY, HIGH-OUTPUT HEART FAILURE, VASOPLEGIA, AND ECMO SUPPORT	84
LAD BRIDGE IS FALLING DOWN: A CASE OF SYMPTOMATIC MYOCARDIAL BRIDGING IN AN ACTIVE DUTY PATIENT	84
A SHOCKING CASE OF TUMOR IN TRANSIT	82
TRENDS OF INTRAVASCULAR IMAGING USE IN BIFURCATION PERCUTANEOUS CORONARY INTERVENTIONS: INSIGHTS FROM THE PROGRESS-BIFURCATION REGISTRY	82
DETECTION OF WATCHMAN DEVICE PERFORATION 45 DAYS POST-IMPLANTATION: A UNIQUE CASE REPORT	82
THE 1-YEAR EFFECTIVENESS OF A REMOTE TEAM-BASED GUIDELINE DIRECTED MEDICATION TITRATION PROGRAM IN TYPE 2 DIABETES AT HIGH CARDIOVASCULAR AND KIDNEY RISK COMPARED WITH STANDARD OF CARE	82
IMPACT OF TRUE BIFURCATION LESIONS ON PROCEDURAL TECHNIQUES AND OUTCOMES OF BIFURCATION PERCUTANEOUS CORONARY INTERVENTION	82
CARDIAC ARRHYTHMIA REGISTRY OF ATHLETES - THE EFFECTS OF CATHETER ABLATION ON QUALITY OF LIFE	82
PATIENT-CENTERED OUTCOMES RESEARCH INSTITUTE (PCORI)’S PORTFOLIO OF COMPARATIVE EFFECTIVENESS RESEARCH (CER) STUDIES ON IMPROVING CARDIOVASCULAR HEALTH	82
TACHY AND BRADY-ARRHYTHMIA MANAGEMENT IN COMPLEX CONGENITAL HEART DISEASE	81
AN UNUSUAL CASE OF NON-TRAUMATIC CHYLOTHORAX POST-CARDIAC TRANSPLANTATION	80
Shining a New Light Into the Black Box	80
RACIAL AND GENDER DISPARITIES IN CLINICAL OUTCOMES OF ACUTE ST-SEGMENT-ELEVATION MYOCARDIAL INFARCTION RELATED MECHANICAL COMPLICATIONS: INSIGHTS FROM THE NATIONAL INPATIENT SAMPLE DATABASE	80
EFFICACY AND SAFETY OF AFICAMTEN IN THE FIRST COHORT OF PATIENTS WITH SYMPTOMATIC OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY COMPLETING 1-YEAR FOLLOW-UP: FINDINGS FROM THE FOREST-HCM STUDY	80
ISOLATED CARDIAC SARCOIDOSIS PRESENTING AS REFRACTORY ATRIAL ARRHYTHMIAS IN A YOUNG HEALTHY FEMALE	80
Cardiac Arrest and Sudden Death	80
Audio Summary	79
The Lancet–JACC Collaboration	79
The Pathogenetic Link Between Ozone Pollution and Cardiovascular Disease	79
Contents	79
Contents	79
Comparative Risk of Angioedema With Sacubitril-Valsartan vs Renin-Angiotensin-Aldosterone Inhibitors	78
Long-Term Outcomes After Fractional Flow Reserve vs Intravascular Ultrasound to Guide PCI	77
Rising Prevalence of Cardiovascular-Kidney-Metabolic Syndrome in China, 2010-2019	77
Reply	77
Exercise Echocardiography for mPAP/CO Slope Estimation	76
Omega-3 Fatty Acid Biomarkers and Incident Atrial Fibrillation	76
Let Us Call It Cardiogenic Preshock	76
Clinical Significance of Diffusion-Weighted Brain MRI Lesions After TAVR	76
Worldwide Chronic Retrieval Experience of Helix-Fixation Leadless Cardiac Pacemakers	76
Relationship Between Control of Cardiovascular Risk Factors and Chronic Kidney Disease Progression, Cardiovascular Disease Events, and Mortality in Chinese Adults	74
10-Year Outcomes of Catheter-Based Renal Denervation in Patients With Resistant Hypertension	74
The Role of Psychosocial Stress on Cardiovascular Disease in Women	74

Patients With Myocarditis Associated With COVID-19 Vaccination	74
TCT-613 Comparison of Histology-Trained Deep Learning Approach With Human Expert Analysts for Automated Plaque Component Classification in Hybrid Intravascular Ultrasound-Optical Coherence Tomography	74
Racial Differences in Diabetic Cardiomyopathy	74
Hyperuricemia and Gout Reduction by SGLT2 Inhibitors in Diabetes and Heart Failure	74
Immune Checkpoint Therapies and Atherosclerosis: Mechanisms and Clinical Implications	73
Dyslipidemia in Human Immunodeficiency Virus Disease	73
Outcomes Associated With Peripheral Artery Disease in Myocardial Infarction With Cardiogenic Shock	72
Audio Summary	72
Impact of Periprocedural Pulmonary Hypertension on Outcomes After Transcatheter Aortic Valve Replacement	72
Quantitative Myocardial Perfusion Predicts Outcomes in Patients With Prior Surgical Revascularization	72
Elevated C-Reactive Protein Amplifies Association of Lipoprotein(a) With Cardiovascular Risk and Clinical Benefit of Alirocumab	72
ACC/AHA/ASE/ASNC/ASPC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2023 Multimodality Appropriate Use Criteria for the Detection and Risk Assessment of Chronic Coronary Disease	72
TCT-845 Impact of Cerebral Embolic Protection on Perioperative Stroke in TAVR for Patients With Atrial Fibrillation	71
TCT-200 Artificial Intelligence Detection of Retrograde Coronary Flow	71
TCT-586 First-in-Human Experience With the Percutaneous Synchronized Cardiac Assist (PSCA) System: Extravascular Mechanical Circulatory Support	71
TCT-480 Blood Pressure Reductions by Radiofrequency Renal Denervation Procedural Characteristics: Pooled 24-Month Results From the SYMPLICITY Clinical Program	70
TCT-911 Vascular Disease in Patients Undergoing Transfemoral Transcatheter Aortic Valve Replacement: From Incidence to Clinical Outcomes	70
TCT-824 Transcatheter Aortic Valve Implantation on Coronary Guidewires: Free-Contrast Technique in Patients With Moderate to Severe Renal Impairment	68
TCT-509 Predictors of Stent Under Expansion in the CALIPSO Trial	68
TCT-873 Biomechanical Analysis of the J-Valve Bioprosthesis: A Computed tomography–Based Computational Study	67
TCT-661 Use of Post–Percutaneous Coronary Intervention Non-hyperemic Pressure Ratios to Guide Procedural Optimization: Cautions and Caveats	67
TCT-64 Left Atrial Appendage Closure: What Is Fabric Edge Leak and How to Treat it?	67
TCT-419 Comparative Clinical Outcomes of Amphilimus-Eluting Stents in Diabetic vs Nondiabetic Patients	67
TCT-290 Survival After PCI or CABG in Patients With NSTEMI and Left Main Disease: A Report From the Registry	66
TCT-183 Periprocedural Continuation vs Interruption of Oral Anticoagulation During Transcatheter Aortic Valve Implantation: Effect on Plasmatic Coagulation and Fibrinolysis	66
TCT-226 Validation of Coronary Angiography–Based FFR Compared With Pressure Wire–Based FFR to Guide Revascularization of Intermediate Coronary Lesions in Nonculprit Vessels in Patients Presenting With	66
TCT-163 Self-Expandable vs Balloon-Expandable Valves in Patients With Small Annuli Undergoing Transfemoral Transcatheter Aortic Valve Implantation	65
TCT-112 Association Between Residual Shunt and the Endothelialization of the Closure Devices for Patent Foramen Ovale (PFO) 12 Months After Implantation Evaluated by Angioscopy	64
TCT-819 Impact of Sodium-Glucose Co-Transporter Inhibitors on Cardiovascular Outcomes in Patients With Acute Myocardial Infarction: A Systematic Review and Meta-Analysis	64
TCT-403 Intravascular Ultrasound Findings Associated With Hydrodynamic Contrast Recanalization of Coronary Chronic Total Occlusions	64
TCT-533 Retrospective Comparison of Device Utilization for Left Atrial Appendage Occlusion: Amulet vs. Watchman	64
TCT-269 Insights From the Danger-SHOCK and ECLS-Shock Trials: A Comparative Analysis	64
TCT-136 We Tested a Novel CT-Guided Algorithm for Transcatheter Aortic Valve Implantation Sizing and Placement in Patients With Severe Bicuspid Aortic Stenosis Incorporating Both Downsizing and Supra-	64
TCT-151 First-in-Human Study of Novel Cerebral Protection in TAVR: An Alternative to Filter-Based Protection	64
TCT-493 Drug-Coated Balloon Angioplasty vs Plain Balloon Angioplasty in Patients With Coronary In-Stent Restenosis: A Meta-Analysis of Randomized Controlled Trials	63
TCT-326 Outcomes of Acute Kidney Injury and Hemodialysis Use in Acute Pulmonary Embolism	63
TCT-442 Tissue Characteristics Can Predict Clinical Outcome in Stent-Less Percutaneous Coronary Intervention With Directional Coronary Atherectomy Followed by Drug-Coated Balloon: Insights From Histol	62
TCT-583 Influence of Heparin-Induced Thrombocytopenia on In-Hospital Outcomes in Patients With Left Ventricular Assist Devices (LVAD): A Decade-Long Study	62
TCT-620 Employment of Artificial Intelligence for an Unbiased Evaluation Regarding the Recovery of Right Ventricular Function After Mitral Valve Transcatheter Edge-to-Edge Repair	62
TCT-39 Comparison of Clinical Outcomes Among Balloon Angioplasty, Drug-Coated Balloon, and the Second or Newer Drug-Eluting Stent	62
TCT-471 Sex-Specific Predictors of Adverse Events in Patients Treated With Advanced Mechanical Circulatory Support	62
TCT-395 Differences in Outcomes Between Rutherford 4 and Rutherford 5/6 Patients Undergoing Endovascular Intervention for Lower Extremity Peripheral Artery Disease	62
TCT-247 Long-Term Follow-Up of Angiographically Intermediate but Hemodynamically Nonsignificant Lesions	61
TCT-949 Long-Term Mechanical Durability of Surgical Aortic Valves: A 2 Billion Cycle In Vitro Study	61
Amara Yad Image: The Relationship of the Atria to the Aorta	60
TCT-251 Practice Patterns and Percutaneous Coronary Intervention Outcomes in University Hospitals: A Comparison Between Sweden and the U.S.	60
EFFICACY AND SAFETY OF THE AGENT PACLITAXEL-COATED BALLOON IN MULTI-LAYER IN-STENT RESTENOSIS - A SUBGROUP ANALYSIS OF THE AGENT IDE RANDOMIZED TRIAL	60
TCT-705 Comparative Outcomes of Endovascular Intervention Versus Bypass Surgery for Peripheral Artery Disease in Patients With Atrial Fibrillation: A Retrospective Analysis of the National Inpatient S	60
STEP-HFpEF	60
TCT-990 Coronary Artery Calcium and Cardiovascular Risk Factors Analysis After Radiotherapy for Breast Cancer: The CLARIFIER: A Gender-Based Preventive Medicine Study	60
Amara Yad Image: The Relationship of the Atria to the Base of the Heart and the Great Vessels	59
Competing Risks in Clinical Trials	59
Bleeding and Thrombotic Risk After Percutaneous Coronary Intervention	59
Prognostic Implications of Initial Focal Contrast Enhancement in Acute Type B Intramural Hematoma	58
Amara Yad Image: The Atria and Their Appendages	58
2025 AHA/ACC Clinical Performance and Quality Measures for Patients With Chronic Coronary Disease	58
Characteristics and Outcomes for Hispanic/Latinx Participants With Statin Intolerance Receiving Bempedoic Acid	57
Low-Risk Patients, High-Impact Trials	57
Outcomes of Percutaneous Mechanical Aspiration in Right-Sided Infective Endocarditis	57
Seeing Is Believing	56
Sacubitril/Valsartan-Related Hypotension in Patients With Heart Failure and Preserved or Mildly Reduced Ejection Fraction	56
PERCUTANEOUS CORONARY INTERVENTION OF TRAUMATIC RIGHT CORONARY ARTERY OCCLUSION FROM A HIGH VELOCITY AIR RIFLE PELLET IN AN ADOLESCENT MALE	56
CARDIAC RETRANSPLANTATION IN A PEDIATRIC PATIENT WITH SEVERE CORONARY ALLOGRAFT VASCULOPATHY	56
ABSENT LEFT CIRCUMFLEX CORONARY ARTERY PRESENTING AS PERSISTENT ISCHEMIC ABNORMALITY	56
MINOCA MYSTERY: FINDING THE CAUSE OF MI	56
THE DUAL DILEMMA: TRANSIENT CONSTRICTIVE PERICARDITIS AND COEXISTENT CHRONIC PLEURAL EFFUSION	56
THE LIMITATIONS OF APICAL SPARING AS AN ECHOCARDIOGRAPHIC PREDICTOR OF CARDIAC AMYLOIDOSIS	56
PREDICTION OF INFLAMMATION IN LEFT ATRIA APPENDAGE BASED ON PATHOLOGICALLY SIZE AND NEW SPECTRAL CT PARAMETERS: SPECIMEN FROM WOLF-OHTSUKA PROCEDURE IN PATIENTS WITH ATRIAL FIBRILLATION AND RECURRENT	55
SURGICAL CLIP AS A CORONARY ARTERY EMBOLISM: A CASE OF NONATHEROSCLEROTIC STEMI	55
HIGH CARDIAC OUTPUT STATE SECONDARY TO SEVERE POSTPARTUM PREECLAMPSIA: A CASE REPORT HIGHLIGHTING DIAGNOSTIC AND MANAGEMENT STRATEGIES	55
THE ROLE OF DEEP LEARNING ALGORITHM INDENTIFYING ATRIAL FIBRILLATION DURING SINUS RHYTHM IN PATIENS WITH CYPTOGENIC STROKE AND PATENT FORAMEN OVALE	55
ST ELEVATON MYOCARDIAL INFARCTION POST SURGICAL AORTIC VALVE REPLACEMENT: ANOMALOUS INDEED	55
PRIMARY HIGH-RISK PCI IN A PATIENT WITH CONGENITALLY CORRECTED TRANSPOSITION OF GREAT ARTERIES AND DEXTROCARDIA AT 40 YEARS OF AGE	55
FROM HEART BLOCK TO VENTRICULAR TACHYCARDIA: THINK SARCOIDOSIS	55
A RARE CASE OF AORTIC ROOT DISSECTION IN THE SETTING OF EXTENSIVE CALCIFICATION IN TRANSCATHETER AORTIC VALVE REPLACEMENT	55
THE DYNAMIC UNRAVELING OF SIGNIFICANT FUNCTIONAL MITRAL REGURGITATION	55
A SUCCESSFUL RESCUE OF POSTPARTUM PULMONARY HYPERTENSION CRISIS BY MULTIDISCIPLINARY COMBINED TREATMENT	54
VENOARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION VERSUS IMPELLA FOR CARDIOGENIC SHOCK IN ACUTE MYOCARDIAL INFARCTION: A SYSTEMATIC REVIEW AND METAANALYSIS	54
INHALED DOXORUBICIN INDUCED CARDIOTOXICITY IN A YOUNG MALE	54
UTILIZATION OF MENTAL HEALTH RESOURCES IN ADULT CONGENITAL HEART PATIENTS WITH DEPRESSION AND ANXIETY	53
ASSOCIATION BETWEEN DELIVERY TYPE AND THE ONSET OF KAWASAKI DISEASE	53
SUCCESSFUL CANNULATION FOR BI-ATRIAL VV-A ECMO IN A PATIENT WITH PRE-EXISTING IVC FILTER	53
LEFT VENTRICULAR UNLOADING REDUCES THE SHORT-TERM MORTALITY IN PATIENTS WITH CARDIOGENIC SHOCK UNDERGOING VENOARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION: NETWORK META-ANALYSIS OF 16,544 PATIENTS	53
EXPLORING THE CLINICAL AND GEOGRAPHIC DISTRIBUTION OF CONGENITAL HEART DISEASE IN HAITI	53
THE EFFECTS OF ALCOHOL CONSUMPTION ON CORONARY ARTERY CALCIFICATION	53
ATRIOVENTRICULAR BLOCK IN A PATIENT TAKING BLACK COHOSH	53
VALIDATION OF THE KANSAS CITY CARDIOMYOPATHY QUESTIONNAIRE-23 IN PATIENTS WITH CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION	53
THE ASSOCIATION OF IMMUNE-MEDIATED INFLAMMATORY DISEASE AND LIPOPROTEIN(A) WITH MAJOR ADVERSE CARDIOVASCULAR EVENTS AMONG INDIVIDUALS WITH AND WITHOUT BASELINE ATHEROSCLEROTICCARDIOVASCULAR DISEASE: T	53
Genetic Testing for Cardiovascular Disease	53
MAVACAMTEN USE FOR OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY IN AN OCTOGENARIAN	53
THE EFFECT OF COMPREHENSIVE ASSESSMENT AND MULTIDISCIPLINARY MANAGEMENT FOR ELDERLY FRAIL PATIENTS WITH CARDIOVASCULAR DISEASES	52
MEXICAN REGISTRY OF CARDIOMYOPATHIES (REMEMI): BASELINE DATA, DIAGNOSIS AND TREATMENT STRATEGIES IN MEXICO	52
COLCHICINE BLOCKS ABDOMINAL AORTIC ANEURYSM DEVELOPMENT BY MAINTAINING VASCULAR SMOOTH MUSCLE CELL HOMEOSTASIS	52
EXPERIENCES OF LGBTQ+ CARDIOLOGY PHYSICIANS AND FELLOWS IN TRAINING	52
SEX DIFFERENCES IN OUTCOMES OF ADULTS WITH REPAIRED COARCTATION OF AORTA AND CONCOMITANT AORTIC VALVE DISEASE	52